Skip to main content
Clinical Trials/NCT02820766
NCT02820766TerminatedNot Applicable

A Non-Randomized, Prospective Study of Short Term Outcomes Following Total Knee Replacement With JOURNEY™ II BCS Total Knee System Compared to Other Posterior Stabilized Total Knee Systems in a Physical Therapy Setting

Smith & Nephew, Inc.3 sites in 1 country22 target enrollmentStarted: September 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
22
Locations
3
Primary Endpoint
Difference in Knee Range of Motion (ROM) at the first outpatient Physical Therapy (PT) visit (≤7 days of surgery) between the 2 treatment groups

Study Overview

Brief Summary

The primary objective of the study is to determine how the short-term outcome of subjects implanted with the JOURNEY™ II BCS Total Knee System compares to subjects implanted with other PS total knee systems, and to determine if there is a difference in health care resources consumed that may result in economic savings to patients, the facility and/or the payer.

To address the study objectives, patient self-assessment questionnaires, and other objective measures of post-operative function and health care resource utilization will be used for data collection.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Undergone unilateral primary total knee replacement with a JOURNEY™ II BCS Total Knee System or other Non-Smith & Nephew Posterior Stabilized Knee System
  • Will be initiating outpatient PT ≤ 7 days post-operatively
  • Has a primary diagnosis of osteoarthritis, degenerative arthritis, or traumatic arthritis
  • Has pre-operative ROM ≥ 90°
  • Is skeletally mature in the PI judgment
  • Is 21 years of age of older
  • Is willing and able to participate in required follow-up visits at the study site and to complete study procedures and questionnaires
  • Has consented to participate in the study by signing the IRB/EC approved informed consent for the study
  • Agrees to follow post- operative physical therapy program

Exclusion Criteria

  • Significant preoperative varus or valgus deformities (>15º)
  • Has received a constrained or deep dish tibial insert
  • Morbid obesity (BMI > 40)
  • Has not obtained required pre-rehabilitation, pre-operative and intra-operative records by week 2 visit
  • Other comorbidities that may impact outcomes such as osteoporosis, uncontrolled diabetes and active infection
  • Fibromyalgia requiring treatment
  • Current or impending incarceration or is a prisoner
  • In the opinion of the PI has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse
  • Is known to be at risk for lost to follow-up, or failure to return for scheduled visits
  • Undergone or is planning to undergo total knee replacement of the contralateral knee within 6 months of this total knee replacement
  • Requires a Legally Authorized Representative to consent to the study

Outcomes

Primary Outcomes

Difference in Knee Range of Motion (ROM) at the first outpatient Physical Therapy (PT) visit (≤7 days of surgery) between the 2 treatment groups

Time Frame: ≤7 days of surgery

The absolute Range of Motion of index knee will be compared between groups

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials